Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL754917 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL8008673 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL11200604 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL3627220 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL150351 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL370655 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL3628151 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL6008847 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL7948040 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL16341798 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109704290-B | Purification method of crystalline sodium sulfide | 铜陵铜冠神虹化工有限责任公司 | 2022-07-26 | — | — | CN | claimed |
| CN-122082088-A | Method for preparing high-length-diameter-ratio calcium sulfate hemihydrate whisker from industrial byproduct gypsum | — | 2026-05-26 | — | — | CN | disclosed |
| US-12534383-B2 | High temperature chemical process for the preparation of cesium tungstate | CARDARELLI FRANCOIS (CA) | 2026-01-27 | — | — | US | disclosed |
| US-20250288624-A1 | LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-09-18 | — | — | US | disclosed |
| WO-2025081966-A1 | COMPOSITE METAL OXIDE CATALYST AND PREPARATION METHOD THEREFOR, AND METHANE CATALYTIC CRACKING METHOD | 中国石油天然气股份有限公司 | 2025-04-24 | — | — | WO | disclosed |
| CN-119857489-A | Composite metal oxide catalyst, preparation method thereof and methane catalytic cracking method | 中国石油天然气股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| US-20250009787-A1 | Nitric Oxide Containing Foam Formulation for Topical Medical Use | NOXY HEALTH PRODUCTS, INC. | 2025-01-09 | — | — | US | disclosed |
| US-20240382517-A1 | Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents | NOXY HEALTH PRODUCTS, INC. | 2024-11-21 | — | — | US | disclosed |
| US-12089591-B2 | Mitigating necrosis in transgenic glyphosate-tolerant cotton plants treated with herbicidal glyphosate formulations | MONSANTO TECHNOLOGY LLC (US) | 2024-09-17 | — | — | US | disclosed |
| EP-3697585-B1 | IMPROVED FLAME RETARDANCY OF WOOD AND OTHER CELLULOSE-BASED MATERIALS BY IN-SITU MINERALIZATION | ETH ZUERICH (CH) | 2024-05-15 | — | — | EP | disclosed |
| US-7452555-B2 | Cocrystallization | S.S.C.I., INC. (US) | 2008-11-18 | — | — | US | disclosed |
| CN-101170907-A | Mitigating necrosis in glyphosate tolerant transgenic cotton plants treated with herbicidal glyphosate formulations | MONSANTO TECHNOLOGY LLC (US) | 2008-04-30 | — | — | CN | disclosed |
| US-20070287194-A1 | Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound | S.S.C.I., INC | 2007-12-13 | — | — | US | disclosed |
| EP-1853115-A2 | MITIGATING NECROSIS IN TRANSGENIC GLYPHOSATE-TOLERANT COTTON PLANTS TREATED WITH HERBICIDAL GLYPHOSATE FORMULATIONS | Monsanto Technology, LLC (US) | 2007-11-14 | — | — | EP | disclosed |
| US-20070088508-A1 | Cocrystallization methods | APTUIT (WEST LAFAYETTE), LLC | 2007-04-19 | — | — | US | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| US-20070037708-A1 | Mitigating necrosis in transgenic glyphosate-tolerant cotton plants treated with herbicidal glyphosate formulations | MONSANTO TECHNOLOGY, LLC (US) | 2007-02-15 | — | — | US | disclosed |
| WO-2006096617-A2 | MITIGATING NECROSIS IN TRANSGENIC GLYPHOSATE-TOLERANT COTTON PLANTS TREATED WITH HERBICIDAL GLYPHOSATE FORMULATIONS | MONSANTO TECHNOLOGY LLC (US) | 2006-09-14 | — | — | WO | disclosed |
| US-4985225-A | MIXING ALUMINUM COMPOUND OR ALUMINUM ALKOXIDE WITH A WATER SOLUBLE CARBON-CONTAINING COMPOUNDS, NITROGEN-CONTAINING COMPOUND; INTEGRATED CIRCUIT CERAMIC SUBSTRATES | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 1991-01-15 | — | — | US | disclosed |
| US-4544793-A | METHANOL OR DIMETHYL ETHER | DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1985-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037708-A1 | Mitigating necrosis in transgenic glyphosate-tolerant cotton plants treated with herbicidal glyphosate formulations | GLO1, AGXT, GRHPR | MEN1 4751/4885ALDH1A1 3322/4885TSHR 2627/4885 |
| US-12534383-B2 | High temperature chemical process for the preparation of cesium tungstate | SOD1, SOD3, CA3 | MEN1 2933/4885ALDH1A1 4174/4885TSHR 2262/4885 |
| US-20250009787-A1 | Nitric Oxide Containing Foam Formulation for Topical Medical Use | NOS1, NOS2, NOS3 | MEN1 4617/4885ALDH1A1 2261/4885TSHR 3209/4885 |
| US-12089591-B2 | Mitigating necrosis in transgenic glyphosate-tolerant cotton plants treated with herbicidal glyphosate formulations | GLO1, AGXT, GRHPR | MEN1 4751/4885ALDH1A1 3322/4885TSHR 2627/4885 |
| US-20240382517-A1 | Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents | NOS2, NOS1, NOS3 | MEN1 4587/4885ALDH1A1 1223/4885TSHR 4742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.